By Matt Grossman

 

Boston Scientific Corp. on Tuesday returned to a profit in the second quarter, as sales recovered amid higher healthcare demand as the coronavirus pandemic eased.

The Marlborough, Mass.-based medical-devices maker logged earnings of 12 cents a share, compared with a loss of 11 cents a share a year earlier. Total net income was $186 million, compared with a net loss of $147 million.

Stripping out one-time items, the company's adjusted earnings were 40 cents a share. Analysts polled by FactSet were forecasting adjusted earnings of 37 cents a share.

Sales rose to $3.08 billion from $2 billion a year earlier, the company said. Analysts had been anticipating sales of $2.94 billion.

Medical-surgical sales rose 65% to $948 million. Rhythm and neuro sales were up 65% at $866 million. Cardiovascular sales improved by 51% to $1.26 billion, the company said.

 

Write to Matt Grossman at matt.grossman@wsj.com

 

(END) Dow Jones Newswires

July 27, 2021 07:02 ET (11:02 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Aug 2021 to Sep 2021 Click Here for more Boston Scientific Charts.
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Sep 2020 to Sep 2021 Click Here for more Boston Scientific Charts.